Current approaches to managing children with ADHD

Announcement:

We present to your attention a speech by Dina Damirovna Gainetdinova, , on one of the most discussed topics in the field of child neurology - attention deficit hyperactivity disorder (ADHD).

Thanks to this video you will learn:

• Why is ADHD not just “restlessness,” but a neuropsychiatric disorder with an organic basis, included in the DSM-5 along with the autism spectrum?
• What are the psychosocial, perinatal and genetic factors underlying the etiology?
• Why do children with ADHD show decreased gray and white matter in the prefrontal cortex and impaired function of the corpus callosum?
• How to recognize ADHD at different stages of development - from infancy to adolescence?

The report examines in detail the clinical picture and age dynamics:

• Increased vocalization and sensory hypersensitivity at an early age;
• Delayed speech development and tic hyperkinesis as the first reasons for seeking medical attention;
• Aggression, sleep disturbances, difficulties in learning and social adaptation in preschool and school age.

Particular attention is paid to differential diagnosis: how to distinguish ADHD from autism spectrum disorder, specific learning disorders and oppositional defiant disorder, and what new treatment options are there?

In 2023, the indication "ADHD" was included in the instructions for medical use of the drug Mexidol, tablets 125 mg. Now it is the first drug with multimodal properties approved for the treatment of ADHD in children from 6 years of age.

Watch the report to:

• Learn to recognize ADHD in its early stages;
• Understand the pathogenetic mechanisms of the disorder;
• Find out how the drug Mexidol can become the basis of complex therapy.

This video is a must-see for pediatricians, child neurologists, psychiatrists, speech therapists and developmental specialists.